Cargando…

Weight loss in patients with head and neck cancer during and after conventional and accelerated radiotherapy

BACKGROUND: Weight loss is common among patients with squamous cell carcinoma of the head and neck (SCCHN) and is mainly due to tumor and treatment related factors. The aim of the present study was to evaluate weight loss in patients with SCCHN undergoing two different radiotherapy (RT) schedules. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ottosson, Sandra, Zackrisson, Björn, Kjellén, Elisabeth, Nilsson, Per, Laurell, Göran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Informa Healthcare 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622234/ https://www.ncbi.nlm.nih.gov/pubmed/23106176 http://dx.doi.org/10.3109/0284186X.2012.731524

Ejemplares similares

Weight and body mass index in relation to irradiated volume and to overall survival in patients with oropharyngeal cancer: a retrospective cohort study
por: Ottosson, Sandra, et al.
Publicado: (2014)

Regional recurrence of oropharyngeal cancer after definitive radiotherapy: a case control study
por: Söderström, Karin, et al.
Publicado: (2015)

Nutritional surveillance and weight loss in head and neck cancer patients
por: Ehrsson, Ylva Tiblom, et al.
Publicado: (2011)

Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy
por: Adrian, Gabriel, et al.
Publicado: (2022)

Accelerated Hyperfractionated Radiotherapy versus Conventional Fractionation Radiotherapy for Head and Neck Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Zhu, Bo, et al.
Publicado: (2019)

PSA decay during salvage radiotherapy for prostate cancer as a predictor of disease outcome – 5 year follow-up of a prospective observational study
por: Gunnlaugsson, Adalsteinn, et al.
Publicado: (2020)

Addressing symptoms that affect patients’ eating according to the Head and Neck Patient Symptom Checklist(©)
por: Granström, Brith, et al.
Publicado: (2022)

Accelerated vs. conventionally fractionated adjuvant radiotherapy in high-risk head and neck cancer: a meta-analysis
por: Matuschek, Christiane, et al.
Publicado: (2018)

A Comparative Prospective Study Between Conventional Chemo-Radiotherapy and Pure Accelerated Radiotherapy With Concurrent Chemotherapy for the Treatment of Locally Advanced Head and Neck Cancer
por: Das, Sumana M, et al.
Publicado: (2023)

Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation
por: Awwad, H K, et al.
Publicado: (2002)

Adaptive sequential plan-on-plan optimization during prostate-specific antigen response guided radiotherapy of recurrent prostate cancer
por: Jóhannesson, Vilberg, et al.
Publicado: (2021)

Long-Term Risk of Hip Complications After Radiation Therapy for Prostate Cancer: A Dose-Response Study
por: Rasmusson, Elisabeth, et al.
Publicado: (2020)

Early mortality after diagnosis of cancer of the head and neck – A population-based nationwide study
por: Talani, Charbél, et al.
Publicado: (2019)

Predicting Return to Work after Head and Neck Cancer Treatment Is Challenging Due to Factors That Affect Work Ability
por: Tiblom Ehrsson, Ylva, et al.
Publicado: (2023)

Early self-care rehabilitation of head and neck cancer patients
por: Ahlberg, Alexander, et al.
Publicado: (2011)

A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and (68)Ga-PSMA-PET for biochemical relapse after radical prostatectomy – The PROPER 1 trial
por: Gunnlaugsson, Adalsteinn, et al.
Publicado: (2022)

A Nordic survey of the management of palliative care in patients with head and neck cancer
por: Boëthius, Helena, et al.
Publicado: (2020)

Systemic Inflammatory Reaction in Patients With Head and Neck Cancer—An Explorative Study
por: Astradsson, Thorsteinn, et al.
Publicado: (2019)

Target definition in radiotherapy of prostate cancer using magnetic resonance imaging only workflow
por: Gunnlaugsson, Adalsteinn, et al.
Publicado: (2019)

Weight Loss in Post-Chemoradiotherapy Head and Neck Cancer Patients
por: Abu Zaid, Zalina, et al.
Publicado: (2022)

Serum Proteomics in Patients with Head and Neck Cancer: Peripheral Blood Immune Response to Treatment
por: Astradsson, Thorsteinn, et al.
Publicado: (2022)

Mechanism and Protection of Radiotherapy Induced Sensorineural Hearing Loss for Head and Neck Cancer
por: Shi, Wenxia, et al.
Publicado: (2021)

Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy
por: Langius, J A E, et al.
Publicado: (2013)

Higher Risk of Recurrence in Patients Treated for Head and Neck Cancer with Low BMI and Elevated Levels of C-Reactive Protein
por: Spiegelberg, Diana, et al.
Publicado: (2022)

Erythropoietin suppresses the activation of pro-apoptotic genes in head and neck squamous cell carcinoma xenografts exposed to surgical trauma
por: Lindgren, Gustaf, et al.
Publicado: (2014)

The effect on the small bowel of 5-FU and oxaliplatin in combination with radiation using a microcolony survival assay
por: Gunnlaugsson, Adalsteinn, et al.
Publicado: (2009)

Head and neck cancer patients’ perceptions of quality of life and how it is affected by the disease and enteral tube feeding during treatment
por: Ehrsson, Ylva Tiblom, et al.
Publicado: (2015)

Longitudinal Changes in the Fatty Acid Profile in Patients with Head and Neck Cancer: Associations with Treatment and Inflammatory Response
por: Christou, Constantina N, et al.
Publicado: (2022)

Comparison of survival rates between patients treated with conventional radiotherapy and helical tomotherapy for head and neck cancer
por: Kong, Moonkyoo, et al.
Publicado: (2013)

Adaptive radiotherapy for head and neck cancer
por: Morgan, Howard E., et al.
Publicado: (2020)

Oral complications of radiotherapy in the head and neck
por: Jham, Bruno Correia, et al.
Publicado: (2015)

Low rate of lymphedema after extended pelvic lymphadenectomy followed by pelvic irradiation of node-positive prostate cancer
por: Rasmusson, Elisabeth, et al.
Publicado: (2013)

The changing landscape of head and neck cancer radiotherapy patients: is high‐risk, prolonged feeding tube use indicative of on‐treatment weight loss?
por: Anderson, Nigel J., et al.
Publicado: (2019)

Accelerated Radiotherapy with Concurrent Chemotherapy in Locally Advanced Head and Neck Cancers: Evaluation of Response and Compliance
por: Mashhour, Karim, et al.
Publicado: (2020)

Evaluation of Acute Toxicity and Early Clinical Outcome in Head and Neck Cancers Treated With Conventional Radiotherapy and Simultaneous Integrated Boost Arc Radiotherapy
por: Bahl, Amit, et al.
Publicado: (2017)

Vitamin D in Head and Neck Cancer: a Systematic Review
por: Mäkitie, Antti, et al.
Publicado: (2020)

ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer
por: Gebre-Medhin, Maria, et al.
Publicado: (2021)

Correlation between egfr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinoma
por: Pedicini, Piernicola, et al.
Publicado: (2012)

What matters to you? – Free-text comments in a questionnaire from patients undergoing radiotherapy
por: Olausson, Kristina, et al.
Publicado: (2019)

Correction: Evaluation of Acute Toxicity and Early Clinical Outcome in Head and Neck Cancers Treated With Conventional Radiotherapy and Simultaneous Integrated Boost Arc Radiotherapy
por: Bahl, Amit, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a0ftl2pep8ae4ndc82e0gru44b